Guy Ungerechts Email & Phone Number | Guy Ungerechts MD, PhD is a medical oncologist trained in the field of oncolytic viruses at Mayo Clinic, Rochester, USA and at the Ottawa Hospital Research Institute (OHRI), Ottawa, Canada. He is Deputy Director of the Medical Oncology Department at the National Center for Tumor Diseases (NCT) Heidelberg, and heads the Clinical Cooperation Unit Virotherapy at DKFZ. His clinical focus is GI oncology with particular interests in translational medicine and early clinical trials of immuno(viro)therapy. Guy has been responsible for the development and conduction of several Phase I/II and III trials with oncolytic viruses derived from different platforms including oncolytic measles virus, vaccinia virus (JX-594), parvovirus H-1 and herpes simplex virus (HSV-1). His group recently demonstrated for the first time that measles virus can be armed with immunomodulatory transgenes encoding for cytokines, immune checkpoint blockade antibodies and bispecific T cell engager (BITEs) for enhanced immunovirotherapy. As a staff medical oncologist, he was member of the GI cancer group at The Ottawa Hospital (TOH) between 2015 and 2017. He is adjunct professor at the University of Ottawa and affiliated investigator at the OHRI in Dr. John Bell´s research program.

Guy Ungerechts

Guy Ungerechts MD, PhD is a medical oncologist trained in the field of oncolytic viruses at Mayo Cli...
Heidelberg, Heidelberg, Germany

*50 free lookup(s) per month.

Guy Ungerechts’s Email g.ungerechts@dkfz.de

Guy Ungerechts’s Phone Numbers +49 6221 56****

Get GUY’s Phone Number (For Free)

Social Media

Guy Ungerechts’s Location Heidelberg, Heidelberg, Germany

Guy Ungerechts’s Current Industry Dkfz German Cancer Research Center National Center For Tumor Diseases Heidelberg Canvirex University Of Ottawa

Guy Ungerechts’s Prior Industry

Find accurate emails & phone numbers for over 700M professionals.

Head of Clinical Cooperation Unit Virotherapy

2019-06-01 00:00:00 - Present

Deputy Director Medical Oncology

2017-10-01 00:00:00 - Present

Founder, CMO & CSO

2017-09-01 00:00:00 - Present

Adjunct Professor

2017-07-01 00:00:00 - Present

No Skills Available

No Languages Available

Guy Ungerechts is a Guy Ungerechts MD, PhD is a medical oncologist trained in the field of oncolytic viruses at Mayo Clinic, Rochester, USA and at the Ottawa Hospital Research Institute (OHRI), Ottawa, Canada. He is Deputy Director of the Medical Oncology Department at the National Center for Tumor Diseases (NCT) Heidelberg, and heads the Clinical Cooperation Unit Virotherapy at DKFZ. His clinical focus is GI oncology with particular interests in translational medicine and early clinical trials of immuno(viro)therapy. Guy has been responsible for the development and conduction of several Phase I/II and III trials with oncolytic viruses derived from different platforms including oncolytic measles virus, vaccinia virus (JX-594), parvovirus H-1 and herpes simplex virus (HSV-1). His group recently demonstrated for the first time that measles virus can be armed with immunomodulatory transgenes encoding for cytokines, immune checkpoint blockade antibodies and bispecific T cell engager (BITEs) for enhanced immunovirotherapy. As a staff medical oncologist, he was member of the GI cancer group at The Ottawa Hospital (TOH) between 2015 and 2017. He is adjunct professor at the University of Ottawa and affiliated investigator at the OHRI in Dr. John Bell´s research program.

Guy Ungerechts currently works in the Dkfz German Cancer Research Center | National Center For Tumor Diseases Heidelberg | Canvirex | University Of Ottawa

Guy Ungerechts has the following professional experience:
Dkfz German Cancer Research Center | National Center For Tumor Diseases Heidelberg | Canvirex | University Of Ottawa